The value to patients of reducing lesion severity in plaque psoriasis.
about
Preference for pharmaceutical formulation and treatment process attributesClinical and histologic diagnostic guidelines for psoriasis: a critical review.Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?A systematic review on methods used to evaluate patient preferences in psoriasis treatments.Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence.Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy.Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment.Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis.Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.Eliciting preferences to inform patient-centred policies: the case of psoriasis.Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study.
P2860
Q26741298-C90EA3E4-2126-48C8-8D02-E734886E6E1EQ34249689-B253CCA3-153C-4D08-A63D-00DFE47489EEQ34718400-C743E596-1239-4B6E-A0E3-7648A9A0D291Q37207116-A018DA08-6A41-46D2-977C-6A6BD0727522Q38768040-446C4AE1-7FE1-4D03-AE9D-730C4B61D2FAQ38840318-184142AD-A4BC-4CD9-9D26-E15393EE6A60Q39011868-747E886D-567D-4AF4-B85F-95A0ED4FC33EQ41255645-2D363CF6-1E36-4F5E-968B-689FF1A80FC9Q45991689-FA1AEDEA-A589-474D-9BF7-E7A75101BB91Q47116889-AB349AC4-8A9F-4B16-A932-769EEE05C9A5Q47733253-B3F2E920-DFB3-481F-9086-2BF6E875CF45Q48093596-3CD2725A-4683-4D79-9DDB-495F1D62D2F5Q53154640-01827659-9AB5-4879-B65D-167ED99A07DCQ55044654-27439823-A759-49B5-A30D-EFCCFFCEB42E
P2860
The value to patients of reducing lesion severity in plaque psoriasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The value to patients of reducing lesion severity in plaque psoriasis.
@en
The value to patients of reducing lesion severity in plaque psoriasis.
@nl
type
label
The value to patients of reducing lesion severity in plaque psoriasis.
@en
The value to patients of reducing lesion severity in plaque psoriasis.
@nl
prefLabel
The value to patients of reducing lesion severity in plaque psoriasis.
@en
The value to patients of reducing lesion severity in plaque psoriasis.
@nl
P2093
P2860
P1476
The value to patients of reducing lesion severity in plaque psoriasis.
@en
P2093
A Brett Hauber
Brad Schenkel
Jennifer H Lofland
Juan Marcos Gonzalez
Silas Martin
P2860
P304
P356
10.3109/09546634.2011.588193
P577
2011-07-24T00:00:00Z